A Phase II, Dose Ranging Study Of CP-690,550 Eye Drops In Patients With Dry Eye Disease

Clinical trial NCT01135511 · COMPLETED

Trial details

NCT number: NCT01135511
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Dry Eye Syndromes

Start date: 2010-07-01
Primary completion: 2011-04-01
Enrollment: 285

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.